Balofloxacin - CAS 127294-70-6
Catalog number: 127294-70-6
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C20H24FN3O4
Molecular Weight:
389.42
COA:
Inquire
Targets:
Antibacterial
Description:
Balofloxacin is a quinolone antibiotic, inhibiting the synthesis of bacterial DNA by interference with the enqyme DNA gyrase.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Synonyms:
N/A
MSDS:
Inquire
1. Ionic liquid based dispersive liquid–liquid microextraction followed by RP-HPLC determination of balofloxacin in rat serum
R. Nageswara Rao,* Ch. Gangu Naidu, Ch. V. Suresh, N. Srinathb and Raju Padiya. Anal. Methods,2014, 6,1674–1683
Accurately weighed 10.0 mg of each balofloxacin and gemifloxacin (IS) (Fig. 1) were separately dissolved in 10.0 mL of MeOH in two volumetric flasks to give 1.0 mg mL-1 individual stock solutions. Working standards of gemifloxacin were prepared by appropriate dilutions of stock solution with MeOH. The working standards were used for the preparation of whole serum calibration standards and also quality control samples. All the stock solutions, calibration standards, and quality control samples were stored at 4 ℃. Calibration standards (range 0.04–10 mg mL-1) were prepared by spiking working standard solutions into serum. These calibration standards were used to test the linearity of themethod. The quality control samples (0.05, 0.1, 2.0 and 7.5 mg mL-1) were prepared by spiking 100 mL of appropriate working standard into 200 mL of serum. The QC samples were used to estimate the extraction recovery (ER) and enrichment factor (EF)s of IL-based DLLME extraction of balofloxacin and gemifloxacin from rat serum.
2. Analysis of trace bromadiolone and brodifacoum in environmental water samples by ionic liquid ultrasound-assisted dispersive liquid–liquid microextraction and LC-MS/MS
Mei-lan Chen, Xiao-hong Chen* and Mi-cong Jin*. Anal. Methods,2014, 6,5879–5885
In 2006, an emerging technique named dispersive liquid–liquid microextraction (DLLME) was developed, which was a novel sample-preparation technique offering high enrichment factors from low volumes of water samples. DLLME has found wide acceptance because of several advantages, including simplicity of operation, rapidity, low cost and ease of method development, which made it available to virtually all analytical laboratories. Today, some studies using DLLME have reported the successful determination of the dye, Brilliant Blue FCF (E133), in different kinds of food and cosmetic samples, linear alkylbenzene sulfonates (LASs) in water samples, ultraviolet filters in water samples, uranium(VI) in water samples, di(2-ethylhexyl) phthalate (DEHP) and its metabolite mono(2-ethylhexyl) phthalate (MEHP) in human urine samples, and balofloxacin in rat serum. DLLME avoids many shortcomings of conventional methods and has been successfully applied for the pre-concentration of organic compounds in environmental and biological fluid samples.
3. The impact of Mycobacterium tuberculosis gyrB point mutations on 6-fluoroquinolones resistance profile: in silico mutagenesis and structure=based assessment
Nikola Minovski,* Marjana Novica and Tom Solmajer. RSC Adv.,2015, 5, 16162–16172
Moreover, the examination of the (T/F)-signed ExpLib compounds selected as correctly/incorrectly positioned within the QBP of each investigated model (3K9Fmod: 84/61, N473Tmod: 40/105, T474Pmod: 42/103, and E475Vmod: 44/101, respectively), identified a total of 27 6-FQ compounds with biological activity values in the range (0.0016 ≤ MICexp [mg mL-1] ≤ 2.000) which are known to be widely used in TB therapy (Table 5). Interestingly, among them only 7 ExpLib compounds (difloxacin, sarafloxacin, clinafloxacin, temafloxacin, moxifloxacin, N-propylciprofloxacin, and balofloxacin) were identifledasnotjustcorrectlypositioned compared to the experimental LFX conformation (see ESI Table S1†), but also active as determined by their biological activity values (MICexp ≤ 1.000 mg mL-1) – a result which additionally allowed the estimation of the 6-FQs resistance, i.e., susceptibility profile for our investigated models (Table 5).
4. Alterations of protein complexes and pathways in genetic information flow and response to stimulus contribute to Escherichia coli resistance to balofloxacin
Hui Li, Jian-Yi Pan, Xuan-Xian Peng*. Mol. BioSyst., 2012, 8, 2303–2311
Cell biochemical processes are performed by a complexome, defined as a set of protein complexes in a cell. Therefore, the identification and characterization of protein complexes is essential to gain a comprehensive understanding of cell functions. Recently, we have presented the first comprehensive characterization of protein complexes of Escherichia coli cleared cell lysates under normal native conditions using 2-D native/ SDS-PAGE based proteomics with co-immunoprecipitation (Co-IP), far-Western blotting, His-tag pull down assays and function analysis, and provided an ideal model system for the investigation of carbohydrate circle and genetic information flow studies in the context of protein–protein interactions. Presently, this approach is used to investigate the altered protein complexes of E. coli in resistance to balofloxacin (BLFX), one of the third generation quinolone antibiotics. Our results demonstrate that not only the modification of the GyrA–GyrB complex, but also the alteration of the other complexes in the genetic information flow, contribute to E. coli resistance to balofloxacin (BLFX). In addition, response to the stimulus pathway is also involved in resistance. These findings broaden and deepen our understanding of bacterial BLFX-resistant mechanisms.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Antibacterial Products


Kasugamycin hydrochloride hydrate
(CAS: 200132-83-8)

Kasugamycin, an aminoglycosidic antibiotic, inhibits protein synthesis by interacting with the 30S ribosomal subunit. The mechanism of inhibition of protein syn...

CAS 62893-19-0 Cefoperazone

Cefoperazone
(CAS: 62893-19-0)

Cefoperazone is a cephalosporin antibiotic for inhibition of rMrp2-mediated [3H]E217βG uptake with IC50 of 199 μM.

CAS 1404-93-9 Vancomycin HCl

Vancomycin HCl
(CAS: 1404-93-9)

Vancomycin HCl is a hydrochloride of vancomycin that is a narrow-spectrum glycopeptide antibacterial agent.

CAS 70458-96-7 Norfloxacin

Norfloxacin
(CAS: 70458-96-7)

Norfloxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria, which functions by inhibiting DNA gyrase. It is...

CAS 136212-91-4 Dermaseptin

Dermaseptin
(CAS: 136212-91-4)

Dermaseptin is a 34-residue antimicrobial peptide.

CAS 122-11-2 Sulphadimethoxine

Sulphadimethoxine
(CAS: 122-11-2)

Sulphadimethoxine is a non-reducing glucuronide.

CAS 364622-82-2 Doripenem Hydrate

Doripenem Hydrate
(CAS: 364622-82-2)

Doripenem Hydrate is an ultra-broad-spectrum injectable antibiotic, used to treat complicated intra-abdominal infections and complicated urinary tract infection...

CAS 17784-12-2 Sulfacytine

Sulfacytine
(CAS: 17784-12-2)

Sulfacytine, a benzenesulfonamide derivative, could be used as an antibiotic through restraining the formation of folate.

CAS 123171-59-5 Cefepime Dihydrochloride Monohydrate

Cefepime Dihydrochloride Monohydrate
(CAS: 123171-59-5)

Cefepime is an extended-spectrum parenteral cephalosporin antibiotic active in vitro against a broad spectrum of gram-positive and gram-negative aerobic bacteri...

CAS 110871-86-8 Sparfloxacin

Sparfloxacin
(CAS: 110871-86-8)

Sparfloxacin is a fluoroquinolone antibiotic, shows broad and potent antibacterial activity.

CAS 25389-94-0 Kanamycin sulfate

Kanamycin sulfate
(CAS: 25389-94-0)

Antibiotic. Inhibits translocation during protein biosynthesis

CAS 55-56-1 Chlorhexidine

Chlorhexidine
(CAS: 55-56-1)

Chlorhexidine is a disinfectant and topical anti-infective agent for reduction of pocket depth in patients with adult periodontitis.

Relebactam
(CAS: 1174018-99-5)

Relebactam, a diazabicyclooctane derivatice, has wide spectrum inhibiting activity of β-lactamases. It has been stuied to be probably effective in the treatment...

CP-5609
(CAS: 432038-96-5)

CP-5609 is a novel carbapenem with enhanced antimicrobial activities.

CAS 186826-86-8 Moxifloxacin HCl

Moxifloxacin HCl
(CAS: 186826-86-8)

Moxifloxacin exerts its effects by trapping a DNA drug enzyme complex and specifically inhibiting ATP-dependent enzymes topoisomerase II (DNA gyrase) and topoisom...

CAS 39831-55-5 Amikacin disulfate

Amikacin disulfate
(CAS: 39831-55-5)

Amikacin sulfate binds to 16S rRNA (bacterial 30S ribosome), causing misreading of mRNA and supressing proteins synthesis.

CAS 101363-10-4 Rufloxacin

Rufloxacin
(CAS: 101363-10-4)

Rufloxacin, a quinolone derivative, is an antibiotic which could restrain the differentiation of B-cell and selectively act on DNA gyrase.

CAS 2058-46-0 Oxytetracycline hydrochloride

Oxytetracycline hydrochloride
(CAS: 2058-46-0)

Oxytetracycline hydrochloride, a tetracycline derivative isolated from the elaboration products of the actinomycete, Streptomyces rimosus, is an antibacterial c...

CAS 131-69-1 Phthalylsulfacetamide

Phthalylsulfacetamide
(CAS: 131-69-1)

Phthalylsulfacetamide, a sulfanilamide derivative, is a predrug of sulfacetamide and could be used as an antibacterial agent.

CAS 1025097-10-2 Cadazolid

Cadazolid
(CAS: 1025097-10-2)

Cadazolid, also referred to ACT-179811,is a new fluoroquinolone-oxazolidinone antibiotic with potent activity against Clostridium difficile.

Chemical Structure

CAS 127294-70-6 Balofloxacin

Quick Inquiry

Verification code

Featured Items